The University of Chicago Header Logo

Connection

Blase Polite to Liver Neoplasms

This is a "connection" page, showing publications Blase Polite has written about Liver Neoplasms.
Connection Strength

0.446
  1. Minimum Requirements to Safely Establish and Sustain New Hepatic Arterial Infusion Pump Programs: An International Expert Perspective. Ann Surg Oncol. 2025 Jun; 32(6):4408-4416.
    View in: PubMed
    Score: 0.144
  2. Single center outcomes from parenchymal-sparing resections and microwave ablations for neuroendocrine tumor liver metastases. Am J Surg. 2024 03; 229:17-23.
    View in: PubMed
    Score: 0.131
  3. Facilities that service economically advantaged neighborhoods perform surgical metastasectomy more often for patients with colorectal liver metastases. Cancer. 2020 01 15; 126(2):281-292.
    View in: PubMed
    Score: 0.100
  4. Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma. Clin Cancer Res. 2012 Apr 01; 18(7):2090-8.
    View in: PubMed
    Score: 0.058
  5. Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium. Invest New Drugs. 2012 Jun; 30(3):1211-5.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.